Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05943509 · ClinicalTrials.gov registry record · NA
Hearing Program in Primary Care
A NA study of Deafness, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05943509: Active NA study of Deafness, sponsored by NYU Langone Health.
NCT05943509 is a NA study of Deafness that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 120 participants, below the 606-participant average among 11 other Deafness trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05943509, a NA study of Deafness, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
During a primary care visit, investigators will screen and identify participants with hearing loss and then randomize to a) counseling on accessible assistive listening devices or b) referral to traditional audiology care pathway alone.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Alternative rehabilitation strategies
Study Locations (1)
New York
- NYC H+H/Bellevue - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2026-01-15 |
| Phase | NA |
What the registry record for NCT05943509 still lists
NCT05943509 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 606-participant average among 11 other Deafness trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Deafness appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT05943509 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05943509 about?
NCT05943509 is a clinical study titled "Hearing Program in Primary Care". During a primary care visit, investigators will screen and identify participants with hearing loss and then randomize to a) counseling on accessible assistive listening devices or b) referral to traditional audiology care pathway alone.
What is the current status of trial NCT05943509?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-02-15. Estimated completion is 2026-01-15.
What conditions does trial NCT05943509 study?
This clinical trial studies the following conditions: Deafness.
What interventions are being tested in trial NCT05943509?
The interventions under investigation include: Usual Care (BEHAVIORAL), Alternative rehabilitation strategies (BEHAVIORAL).
Who is sponsoring clinical trial NCT05943509?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05943509 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deafness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05943509's enrollment target sits among peer trials
120 7th of 11 higher than 5 of 11 other Deafness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Deafness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
RECRUITING · NA
-
Novel Coding Strategies for Children With Cochlear Implants
RECRUITING · NA
-
Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures
RECRUITING · NA
-
Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI